# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The estate of Henrietta Lacks can proceed with a lawsuit against Ultragenyx Pharmaceutical over the use of HeLa cells taken wit...
HSBC analyst Rajesh Kumar maintains Thermo Fisher Scientific (NYSE:TMO) with a Buy and raises the price target from $660 to ...
Under this agreement, Thermo Fisher, through the European arm of its Fisher Scientific Channel, will distribute Bio-Techne'...
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and...